Aviva PLC grew its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 81,230 shares of the company’s stock after purchasing an additional 4,195 shares during the quarter. Aviva PLC owned about 0.16% of U.S. Physical Therapy worth $3,609,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Tower Research Capital LLC TRC boosted its stake in shares of U.S. Physical Therapy by 15,474.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 1,245 shares of the company’s stock worth $119,000 after purchasing an additional 1,214 shares during the period. Chicago Partners Investment Group LLC bought a new position in shares of U.S. Physical Therapy during the 3rd quarter worth about $202,000. Finally, Ameritas Investment Partners Inc. boosted its stake in shares of U.S. Physical Therapy by 14.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,784 shares of the company’s stock worth $129,000 after purchasing an additional 346 shares during the period.
Get U.S. Physical Therapy alerts:
Several equities research analysts have commented on the stock. DA Davidson lowered their price objective on shares of U.S. Physical Therapy from $52.00 to $50.00 and set a “buy” rating for the company in a research note on Friday, February 16th. Stifel Nicolaus raised their price objective on shares of U.S. Physical Therapy from $40.00 to $47.00 and gave the company a “hold” rating in a research note on Monday, February 26th.
U.S. Physical Therapy ( NYSE USPH ) opened at $48.25 on Monday. The company has a market cap of $2,460.00, a P/E ratio of 22.02, a PEG ratio of 1.09 and a beta of 0.66. U.S. Physical Therapy has a 12 month low of $30.10 and a 12 month high of $50.99.
U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, February 15th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.49 by $0.09. The firm had revenue of $145.85 million during the quarter, compared to analysts’ expectations of $147.61 million. U.S. Physical Therapy had a net margin of 5.97% and a return on equity of 17.89%. U.S. Physical Therapy’s revenue for the quarter was up 17.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.50 earnings per share. equities research analysts anticipate that U.S. Physical Therapy will post 2.69 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 29th. Investors of record on Thursday, March 15th will be issued a $0.325 dividend. This represents a $1.20 annualized dividend and a yield of 2.77%. The ex-dividend date is Wednesday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 98.00%.
WARNING: This report was posted by American Banking News and is the sole property of of American Banking News. If you are reading this report on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this report can be read at .
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, together with its subsidiaries, owns and operates physical therapy and wellness centers in the United States. It operates through two segments, Physical Therapy and Wellness. The company offers therapeutic services to the outpatient market, including specialists in physical therapy for treating back and joint pain, osteoarthritis of the knee, and neuromuscular disorders and injuries.
Recommended Story: What does